GSK-3923868

N/A

Report date: 2024/08/30 15:26:52
NME

Base Information

Drug NameGSK-3923868
Drug Alias NameGSK-3923868
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-kinase beta inhibitors
TargetsPhosphatidylinositol 4-kinase beta
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveRespiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A